77 related articles for article (PubMed ID: 18785023)
1. Genomic differences between retinoma and retinoblastoma.
Sampieri K; Mencarelli MA; Epistolato MC; Toti P; Lazzi S; Bruttini M; De Francesco S; Longo I; Meloni I; Mari F; Acquaviva A; Hadjistilianou T; Renieri A; Ariani F
Acta Oncol; 2008; 47(8):1483-92. PubMed ID: 18785023
[TBL] [Abstract][Full Text] [Related]
2. Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression.
Stachelek K; Harutyunyan N; Lee S; Beck A; Kim J; Xu L; Berry JL; Nagiel A; Reynolds CP; Murphree AL; Lee TC; Aparicio JG; Cobrinik D
Genes Chromosomes Cancer; 2023 May; 62(5):275-289. PubMed ID: 36550020
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma and polydactyly in a child with 46, XY, 15pstk+ karyotype-A case report and literature review.
Pi X; Zhang Q; Wang X; Jiang F
Mol Genet Genomic Med; 2024 Mar; 12(3):e2414. PubMed ID: 38465842
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Imaging for Retinoblastoma Cancer Staging: Guide for Providing Essential Insights for Ophthalmologists and Oncologists.
Pai V; Muthusami P; Ertl-Wagner B; Shroff MM; Parra-Fariñas C; Sainani K; Kletke S; Brundler MA; Mallipatna A
Radiographics; 2024 Apr; 44(4):e230125. PubMed ID: 38451848
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma with MYCN Amplification Diagnosed from Cell-Free DNA in the Aqueous Humor.
Joseph S; Pike S; Peng CC; Brown B; Xu L; Berry JL; Chévez-Barrios P; Hubbard GB; Grossniklaus HE
Ocul Oncol Pathol; 2024 Apr; 10(1):15-24. PubMed ID: 38751495
[TBL] [Abstract][Full Text] [Related]
6. Retinoma in a 14-year-old girl.
Rimbert N; Matet A; Lumbroso L
J Fr Ophtalmol; 2024 May; 47(7):104193. PubMed ID: 38714027
[No Abstract] [Full Text] [Related]
7. Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation?
Gallie BL; Ellsworth RM; Abramson DH; Phillips RA
Br J Cancer; 1982 Apr; 45(4):513-21. PubMed ID: 7073943
[TBL] [Abstract][Full Text] [Related]
8. The genomic landscape of retinoblastoma: a review.
Thériault BL; Dimaras H; Gallie BL; Corson TW
Clin Exp Ophthalmol; 2014; 42(1):33-52. PubMed ID: 24433356
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
[TBL] [Abstract][Full Text] [Related]
10. Array comparative genomic hybridization in retinoma and retinoblastoma tissues.
Sampieri K; Amenduni M; Papa FT; Katzaki E; Mencarelli MA; Marozza A; Epistolato MC; Toti P; Lazzi S; Bruttini M; De Filippis R; De Francesco S; Longo I; Meloni I; Mari F; Acquaviva A; Hadjistilianou T; Renieri A; Ariani F
Cancer Sci; 2009 Mar; 100(3):465-71. PubMed ID: 19183342
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific targeting of cell fate regulatory genes by E2f factors.
Julian LM; Liu Y; Pakenham CA; Dugal-Tessier D; Ruzhynsky V; Bae S; Tsai SY; Leone G; Slack RS; Blais A
Cell Death Differ; 2016 Apr; 23(4):565-75. PubMed ID: 25909886
[TBL] [Abstract][Full Text] [Related]
12. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development.
Chong JL; Tsai SY; Sharma N; Opavsky R; Price R; Wu L; Fernandez SA; Leone G
Mol Cell Biol; 2009 Jan; 29(2):414-24. PubMed ID: 19015245
[TBL] [Abstract][Full Text] [Related]
13. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.
Qi DL; Cobrinik D
Oncogene; 2017 Mar; 36(13):1760-1769. PubMed ID: 27748758
[TBL] [Abstract][Full Text] [Related]
14. Role of MYCN in retinoblastoma.
Felsher DW
Lancet Oncol; 2013 Apr; 14(4):270-1. PubMed ID: 23498720
[No Abstract] [Full Text] [Related]
15. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
16. Genetics and Molecular Diagnostics in Retinoblastoma--An Update.
Soliman SE; Racher H; Zhang C; MacDonald H; Gallie BL
Asia Pac J Ophthalmol (Phila); 2017; 6(2):197-207. PubMed ID: 28399338
[TBL] [Abstract][Full Text] [Related]
17. Functional genomics identifies new synergistic therapies for retinoblastoma.
Aubry A; Pearson JD; Huang K; Livne-Bar I; Ahmad M; Jagadeesan M; Khetan V; Ketela T; Brown KR; Yu T; Lu S; Wrana JL; Moffat J; Bremner R
Oncogene; 2020 Jul; 39(31):5338-5357. PubMed ID: 32572160
[TBL] [Abstract][Full Text] [Related]
18. Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma.
Winter U; Ganiewich D; Ottaviani D; Zugbi S; Aschero R; Sendoya JM; Cafferata EG; Mena M; Sgroi M; Sampor C; Lubieniecki F; Fandiño A; Abba MC; Doz F; Podhjacer O; Carcaboso AM; Letouzé E; Radvanyi F; Chantada GL; Llera AS; Schaiquevich P
JAMA Ophthalmol; 2020 May; 138(5):569-574. PubMed ID: 32191268
[TBL] [Abstract][Full Text] [Related]
19. Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy.
Aubry A; Yu T; Bremner R
Cell Death Discov; 2020; 6():2. PubMed ID: 32123578
[No Abstract] [Full Text] [Related]
20. Next-Generation Technologies and Strategies for the Management of Retinoblastoma.
Gudiseva HV; Berry JL; Polski A; Tummina SJ; O'Brien JM
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
